Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.

Hernandez I, He M, Chen N, Brooks MM, Saba S, Gellad WF.

J Am Heart Assoc. 2019 Jun 18;8(12):e011427. doi: 10.1161/JAHA.118.011427. Epub 2019 Jun 13.

2.

Emergency Physician Opioid Prescribing and Risk of Long-term Use in the Veterans Health Administration: an Observational Analysis.

Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF.

J Gen Intern Med. 2019 May 29. doi: 10.1007/s11606-019-05023-5. [Epub ahead of print]

PMID:
31144281
3.

Comparison of Opioid Prescribing by Dentists in the United States and England.

Suda KJ, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, Rowan SA, Thornhill MH.

JAMA Netw Open. 2019 May 3;2(5):e194303. doi: 10.1001/jamanetworkopen.2019.4303.

PMID:
31125102
4.

Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare.

Radomski TR, Zhao X, Hanlon JT, Thorpe JM, Thorpe CT, Naples JG, Sileanu FE, Cashy JP, Hale JA, Mor MK, Hausmann LRM, Donohue JM, Suda KJ, Stroupe KT, Good CB, Fine MJ, Gellad WF.

Healthc (Amst). 2019 Apr 25. pii: S2213-0764(18)30230-6. doi: 10.1016/j.hjdsi.2019.04.003. [Epub ahead of print]

PMID:
31031120
5.

A New Safe Harbor - Turning Drug Rebates into Discounts in Medicare Part D.

Gellad WF, Ennis M, Kuza CC.

N Engl J Med. 2019 May 2;380(18):1688-1690. doi: 10.1056/NEJMp1902692. Epub 2019 Apr 3. No abstract available.

PMID:
30946552
6.

Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data.

Hernandez I, Shrank WH, Good CB, Gellad WF.

J Gen Intern Med. 2019 Apr 3. doi: 10.1007/s11606-019-04989-6. [Epub ahead of print] No abstract available.

PMID:
30945066
7.

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.

Hernandez I, Good CB, Shrank WH, Gellad WF.

JAMA. 2019 Mar 25. doi: 10.1001/jama.2019.2990. [Epub ahead of print] No abstract available.

PMID:
30907933
8.

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.

Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF.

JAMA Netw Open. 2019 Mar 1;2(3):e190968. doi: 10.1001/jamanetworkopen.2019.0968.

PMID:
30901048
9.

The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.

Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM.

J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.

PMID:
30887440
10.

Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.

Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Ann Intern Med. 2019 Mar 12. doi: 10.7326/M18-2574. [Epub ahead of print]

PMID:
30856660
11.

Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM).

Chinman M, Gellad WF, McCarthy S, Gordon AJ, Rogal S, Mor MK, Hausmann LRM.

Implement Sci. 2019 Jan 18;14(1):5. doi: 10.1186/s13012-019-0852-z.

12.

Assessment of Spending in Medicare Part D If Medication Prices From the Department of Veterans Affairs Were Used.

Venker B, Stephenson KB, Gellad WF.

JAMA Intern Med. 2019 Jan 14. doi: 10.1001/jamainternmed.2018.5874. [Epub ahead of print] No abstract available.

PMID:
30640367
13.

Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness.

Minegishi T, Frakt AB, Garrido MM, Gellad WF, Hausmann LRM, Lewis ET, Pizer SD, Trafton JA, Oliva EM.

Subst Abus. 2019;40(1):14-19. doi: 10.1080/08897077.2018.1540376. Epub 2019 Jan 8.

PMID:
30620691
14.

The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs.

Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH.

Health Aff (Millwood). 2019 Jan;38(1):76-83. doi: 10.1377/hlthaff.2018.05147.

PMID:
30615532
15.

Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans.

Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Res Social Adm Pharm. 2018 Oct 17. pii: S1551-7411(18)30282-1. doi: 10.1016/j.sapharm.2018.10.023. [Epub ahead of print]

PMID:
30385111
16.

Characteristics of Opioid Prescriptions to Veterans With Cirrhosis.

Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF.

Clin Gastroenterol Hepatol. 2019 May;17(6):1165-1174.e3. doi: 10.1016/j.cgh.2018.10.021. Epub 2018 Oct 17.

PMID:
30342261
17.

Adaptation and Initial Validation of Minimum Data Set (MDS) Mortality Risk Index to MDS Version 3.0.

Niznik JD, Zhang S, Mor MK, Zhao X, Ersek M, Aspinall SL, Gellad WF, Thorpe JM, Hanlon JT, Schleiden LJ, Springer S, Thorpe CT.

J Am Geriatr Soc. 2018 Dec;66(12):2353-2359. doi: 10.1111/jgs.15579. Epub 2018 Oct 18.

PMID:
30335184
18.

Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia.

Thorpe CT, Gellad WF, Mor MK, Cashy JP, Pleis JR, Van Houtven CH, Schleiden LJ, Hanlon JT, Niznik JD, Carico RL Jr, Good CB, Thorpe JM.

Health Serv Res. 2018 Dec;53 Suppl 3:5375-5401. doi: 10.1111/1475-6773.13055. Epub 2018 Oct 16.

PMID:
30328097
19.

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply.

Hernandez I, Prasad V, Gellad WF.

JAMA Oncol. 2018 Dec 1;4(12):1785-1786. doi: 10.1001/jamaoncol.2018.4657. No abstract available.

PMID:
30325998
20.

Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.

Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Suda KJ, Stroupe K, Hanlon JT, Good CB, Fine MJ, Gellad WF.

Ann Intern Med. 2018 Nov 6;169(9):593-601. doi: 10.7326/M18-0852. Epub 2018 Oct 9.

PMID:
30304353
21.

Influence of peer networks on physician adoption of new drugs.

Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, Zhang R, Lo-Ciganic WH, Junker SP, Anderson T, Richards-Shubik S.

PLoS One. 2018 Oct 1;13(10):e0204826. doi: 10.1371/journal.pone.0204826. eCollection 2018.

22.

Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part D.

Schleiden LJ, Thorpe CT, Cashy JP, Gellad WF, Good CB, Hanlon JT, Mor MK, Niznik JD, Pleis JR, Van Houtven CH, Thorpe JM.

Res Social Adm Pharm. 2019 Jun;15(6):701-709. doi: 10.1016/j.sapharm.2018.09.001. Epub 2018 Sep 8.

PMID:
30236896
23.

Lowering the P Value Threshold.

Hernandez I, Gellad WF, Good CB.

JAMA. 2018 Sep 4;320(9):935. doi: 10.1001/jama.2018.8733. No abstract available.

PMID:
30193271
24.

Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.

Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Chang CH, Kelley D, Donohue JM.

J Manag Care Spec Pharm. 2018 Sep;24(9):875-885. doi: 10.18553/jmcp.2018.24.9.875.

25.

High Variability of Opioid Prescribing Within and Across Emergency Departments in the US Veterans Health Administration.

Sowicz TJ, Gordon AJ, Gellad WF, Zhao X, Zhang H, Emmendorfer T, Good CB.

J Gen Intern Med. 2018 Nov;33(11):1831-1832. doi: 10.1007/s11606-018-4588-2. No abstract available.

PMID:
30039496
26.

Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies.

Anderson TS, Good CB, Gellad WF.

J Gen Intern Med. 2018 Oct;33(10):1604-1606. doi: 10.1007/s11606-018-4527-2. No abstract available.

PMID:
29948812
27.

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy.

Hernandez I, Prasad V, Gellad WF.

JAMA Oncol. 2018 Jul 1;4(7):994-996. doi: 10.1001/jamaoncol.2018.0977. No abstract available.

28.

Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.

Radomski TR, Bixler FR, Zickmund SL, Roman KM, Thorpe CT, Hale JA, Sileanu FE, Hausmann LRM, Thorpe JM, Suda KJ, Stroupe KT, Gordon AJ, Good CB, Fine MJ, Gellad WF.

J Gen Intern Med. 2018 Aug;33(8):1253-1259. doi: 10.1007/s11606-018-4374-1. Epub 2018 Mar 8.

PMID:
29520747
29.

Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B Debate.

Gellad WF, James AE.

N Engl J Med. 2018 Feb 8;378(6):501-503. doi: 10.1056/NEJMp1716139. Epub 2018 Jan 24. No abstract available.

PMID:
29365283
30.

Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use.

Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ.

Am J Public Health. 2018 Feb;108(2):248-255. doi: 10.2105/AJPH.2017.304174. Epub 2017 Dec 21.

31.

Patterns and predictors of physician adoption of new cardiovascular drugs.

Anderson TS, Lo-Ciganic WH, Gellad WF, Zhang R, Huskamp HA, Choudhry NK, Chang CH, Richards-Shubik S, Guclu H, Jones B, Donohue JM.

Healthc (Amst). 2018 Mar;6(1):33-40. doi: 10.1016/j.hjdsi.2017.09.004. Epub 2017 Oct 21.

32.

The myths of medication adherence.

Gellad WF, Thorpe CT, Steiner JF, Voils CI.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1437-1441. doi: 10.1002/pds.4334. Epub 2017 Oct 10. No abstract available.

PMID:
28994158
33.

Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid.

Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM.

JAMA. 2017 Aug 22;318(8):750-752. doi: 10.1001/jama.2017.7818. No abstract available.

34.

Medicaid prior authorization and opioid medication abuse and overdose.

Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM.

Am J Manag Care. 2017 May 1;23(5):e164-e171.

35.

Limitations Concerning the Association of Physician Sex and Patient Outcomes.

Friedberg MW, Gellad WF, Prasad V.

JAMA Intern Med. 2017 Jul 1;177(7):1058. doi: 10.1001/jamainternmed.2017.2142. No abstract available.

PMID:
28672361
36.

Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.

Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH.

Clin Ther. 2017 Jul;39(7):1456-1478.e36. doi: 10.1016/j.clinthera.2017.05.358. Epub 2017 Jun 28. Review.

PMID:
28668628
37.

Accelerated Approval and Expensive Drugs - A Challenging Combination.

Gellad WF, Kesselheim AS.

N Engl J Med. 2017 May 25;376(21):2001-2004. doi: 10.1056/NEJMp1700446. No abstract available.

PMID:
28538133
38.

The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use.

Radomski TR, Zhao X, Thorpe CT, Thorpe JM, Naples JG, Mor MK, Good CB, Fine MJ, Gellad WF.

J Gen Intern Med. 2017 Sep;32(9):967-973. doi: 10.1007/s11606-017-4064-4. Epub 2017 May 1.

39.

Commentary on Daubresse et al. (2017): An epidemic of outdated data.

Gellad WF.

Addiction. 2017 Jun;112(6):1054-1055. doi: 10.1111/add.13817. No abstract available.

PMID:
28447431
40.

Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.

Suda KJ, Smith BM, Bailey L, Gellad WF, Huo Z, Burk M, Cunningham F, Stroupe KT.

J Am Pharm Assoc (2003). 2017 May - Jun;57(3):333-340.e3. doi: 10.1016/j.japh.2017.02.018. Epub 2017 Apr 10.

PMID:
28408172
41.

Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs.

Gellad WF, Good CB, Shulkin DJ.

JAMA Intern Med. 2017 May 1;177(5):611-612. doi: 10.1001/jamainternmed.2017.0147. No abstract available.

PMID:
28288245
42.

Pharmacy Use in the First Year of the Veterans Choice Program: A Mixed-methods Evaluation.

Gellad WF, Cunningham FE, Good CB, Thorpe JM, Thorpe CT, Bair B, Roman K, Zickmund SL.

Med Care. 2017 Jul;55 Suppl 7 Suppl 1:S26-S32. doi: 10.1097/MLR.0000000000000661.

PMID:
28221274
43.

Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.

Tang Y, Horvitz-Lennon M, Gellad WF, Lave JR, Chang CH, Normand SL, Donohue JM.

Psychiatr Serv. 2017 Jun 1;68(6):579-586. doi: 10.1176/appi.ps.201600041. Epub 2017 Feb 15.

PMID:
28196460
44.

Medication acquisition by veterans dually eligible for Veterans Affairs and Medicare Part D pharmacy benefits.

Stroupe KT, Smith BM, Bailey L, Adas J, Gellad WF, Suda K, Huo Z, Tully S, Burk M, Cunningham F.

Am J Health Syst Pharm. 2017 Feb 1;74(3):140-150. doi: 10.2146/ajhp150800.

PMID:
28122756
45.

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM.

Med Care. 2017 Mar;55(3):291-298. doi: 10.1097/MLR.0000000000000676.

46.

Long-term disease and economic outcomes of prior authorization criteria for Hepatitis C treatment in Pennsylvania Medicaid.

Kabiri M, Chhatwal J, Donohue JM, Roberts MS, James AE, Dunn MA, Gellad WF.

Healthc (Amst). 2017 Sep;5(3):105-111. doi: 10.1016/j.hjdsi.2016.11.001. Epub 2016 Dec 5.

47.

Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D.

Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB.

Subst Abus. 2017 Jan-Mar;38(1):22-25. doi: 10.1080/08897077.2016.1267071. Epub 2016 Dec 7.

48.

Dual Health Care System Use and High-Risk Prescribing in Patients With Dementia: A National Cohort Study.

Thorpe JM, Thorpe CT, Gellad WF, Good CB, Hanlon JT, Mor MK, Pleis JR, Schleiden LJ, Van Houtven CH.

Ann Intern Med. 2017 Feb 7;166(3):157-163. doi: 10.7326/M16-0551. Epub 2016 Dec 6.

PMID:
27919104
49.

Improving Medication Adherence: Keep Your Eyes on the Prize.

Marcum ZA, Gellad WF.

J Gen Intern Med. 2017 Mar;32(3):236-237. doi: 10.1007/s11606-016-3927-4. No abstract available.

50.

The Role of Opioid Analgesics in Geriatric Pain Management.

Naples JG, Gellad WF, Hanlon JT.

Clin Geriatr Med. 2016 Nov;32(4):725-735. doi: 10.1016/j.cger.2016.06.006. Epub 2016 Aug 9. Review.

Supplemental Content

Loading ...
Support Center